Status:
UNKNOWN
Thrombophilia Assessment Under DOAC: Effectiveness of Activated Charcoal
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Thrombophilia
Eligibility:
All Genders
18+ years
Brief Summary
Direct oral anticoagulants (DOAC) are anticoagulant molecules that act either directly on factor Xa (Apixaban, Rivaroxaban) or on factor IIa (Dabigatran). AODs interfere with most coagulation tests, ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Adult subject (≥ 18 years of age)
- Blood sample already analyzed in a usual way in the laboratory as part of the care
- Subject not objecting to the reuse of his or her medical data for scientific research purposes.
- Exclusion criteria:
- \- Insufficient sample
Exclusion
Key Trial Info
Start Date :
July 19 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 19 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06171984
Start Date
July 19 2022
End Date
January 19 2024
Last Update
December 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laboratoire d'Hématologie - CHU de Strasbourg - France
Strasbourg, France, 67091